2000
DOI: 10.1046/j.1365-2958.2000.01829.x
|View full text |Cite
|
Sign up to set email alerts
|

NADP and NAD utilization in Haemophilus influenzae

Abstract: SummaryExogenous NAD utilization or pyridine nucleotide cycle metabolism is used by many bacteria to maintain NAD turnover and to limit energy-dependent de novo NAD synthesis. The genus Haemophilus includes several important pathogenic bacterial species that require NAD as an essential growth factor. The molecular mechanisms of NAD uptake and processing are understood only in part for Haemophilus. In this report, we present data showing that the outer membrane lipoprotein e(P4), encoded by the hel gene, and an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
77
0
1

Year Published

2003
2003
2019
2019

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 56 publications
(79 citation statements)
references
References 41 publications
1
77
0
1
Order By: Relevance
“…The first report that e (P4) is involved in heme utilization was based on the ability of cloned e (P4) to complement an E. coli hemA mutant for growth on heme, and the apparently reduced ability of a hel insertion mutant to grow on media supplemented with NAD and either heme or hemoglobin [3]. Subsequent studies demonstrated that e (P4) is involved in the utilization of NAD and NADP and led the authors to "argue that the original observed aerobic growth defect of hel mutant strains is based on a deficiency in using factor V and not haemin" [6]. Such a conclusion seems unlikely since 1) it fails to explain the ability of cloned hel to complement a hemA mutant of E. coli for growth on heme and 2) it does not address the fact that there was no reported growth defect for the hel insertion mutants when grown anaerobically.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The first report that e (P4) is involved in heme utilization was based on the ability of cloned e (P4) to complement an E. coli hemA mutant for growth on heme, and the apparently reduced ability of a hel insertion mutant to grow on media supplemented with NAD and either heme or hemoglobin [3]. Subsequent studies demonstrated that e (P4) is involved in the utilization of NAD and NADP and led the authors to "argue that the original observed aerobic growth defect of hel mutant strains is based on a deficiency in using factor V and not haemin" [6]. Such a conclusion seems unlikely since 1) it fails to explain the ability of cloned hel to complement a hemA mutant of E. coli for growth on heme and 2) it does not address the fact that there was no reported growth defect for the hel insertion mutants when grown anaerobically.…”
Section: Discussionmentioning
confidence: 99%
“…Reilly et al subsequently identified e (P4) as a phosphomonoesterase [4,5], while Reidl et al reported that e (P4) has NADP phosphatase activity and is required for utilization of NAD and NADP [6]. Reidl et al concluded that the report with respect to heme utilization was erroneous, stating "it seems unlikely that e (P4) is involved in haem uptake" [6].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…This model also may hold true for Ftp-containing bacteria that require periplasmic FMN but lack the Shewanella export/nucleotidase pair. There is an analogous mechanism for NAD uptake and processing by an NAD pyrophosphatase in the periplasm of Haemophilus influenza, which has a requirement for the cofactor (79,80). Nonetheless, the possibility of FAD pyrophosphatases in other pathogenic bacteria deserves further investigation.…”
Section: ϩmentioning
confidence: 99%
“…This implies that NR is the substrate for an as yet unidentified inner membrane transporter. Recently, we presented data showing that two gene products appear to be involved in the NAD utilization pathway of H. influenzae (12)(13)(14). The gene products were identified as the hel-encoded outer membrane lipoprotein e(P4) and a periplasmic protein termed NadN.…”
mentioning
confidence: 99%